Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Susan Carol Smith
Introduction
Susan Carol Smith is a notable inventor based in San Antonio, TX (US). She has made significant strides in the field of oncology, particularly in the treatment of acute myeloid leukemia (AML). Her work has the potential to impact the lives of many patients suffering from this challenging disease.
Latest Patents
Susan holds a patent for her innovative approach to treating acute myeloid leukemia (AML) in patients who have experienced disease progression after prior therapies involving venetoclax. The patent outlines various treatment regimens that utilize alvocidib, either as a standalone therapy or in combination with cytarabine or hypomethylating agents like decitabine or azacitidine. Importantly, these regimens do not involve the combination of alvocidib with venetoclax, marking a significant advancement in AML treatment options. She has 1 patent to her name.
Career Highlights
Susan is currently associated with Sumitomo Pharma Oncology, Inc., where she continues to develop innovative therapies for cancer treatment. Her dedication to research and development in oncology has positioned her as a key figure in the fight against AML.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues, including David J Bearss and Stephen Patrick Anthony. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatments.
Conclusion
Susan Carol Smith's contributions to the field of oncology, particularly in the treatment of acute myeloid leukemia, highlight her innovative spirit and commitment to improving patient outcomes. Her work exemplifies the impact that dedicated inventors can have on medical science and patient care.